QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
QQQ   328.11 (+0.83%)
AAPL   142.92 (+2.77%)
MSFT   229.53 (+1.58%)
FB   278.01 (+1.28%)
GOOGL   1,894.28 (+0.09%)
AMZN   3,294.00 (+0.05%)
TSLA   880.80 (+4.03%)
NVDA   546.13 (-0.43%)
BABA   261.38 (+1.07%)
CGC   32.91 (-2.63%)
GE   10.99 (-1.08%)
MU   81.28 (-1.22%)
AMD   94.13 (+1.44%)
NIO   59.99 (-3.16%)
T   29.11 (+0.62%)
F   11.29 (-2.00%)
ACB   10.16 (-4.60%)
BA   203.36 (-1.20%)
DIS   171.89 (-0.52%)
NFLX   556.78 (-1.48%)
GILD   68.16 (+1.82%)
Log in
NASDAQ:FGEN

FibroGen SEC Filings & 10K Form

$49.59
+2.03 (+4.27 %)
(As of 01/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$46.87
Now: $49.59
$49.59
50-Day Range
$37.09
MA: $41.08
$47.56
52-Week Range
$22.65
Now: $49.59
$51.56
Volume787,619 shs
Average Volume704,424 shs
Market Capitalization$4.51 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.59

SEC Filings

FibroGen (NASDAQ:FGEN) SEC Filings

DateFilerForm TypeView
01/21/2021
6:24 PM
FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2021
7:02 PM
FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
6:40 PM
Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
9:04 AM
FibroGen (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SC 13G/A
01/06/2021
6:08 PM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2020
5:07 PM
FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
4:10 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2020
6:06 PM
FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
6:04 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
6:34 PM
FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
6:33 PM
FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
6:30 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
6:27 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2020
5:51 PM
Eisner Mark (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2020
5:41 PM
Eisner Mark (Reporting)
FibroGen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/01/2020
7:05 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2020
3:52 PM
FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2020
3:45 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
3:13 PM
FibroGen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/18/2020
4:19 PM
FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2020
12:19 PM
FibroGen (Filer)
Form CT ORDER
09/17/2020
5:03 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
6:36 PM
FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
6:32 PM
FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
6:30 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
6:28 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2020
3:33 PM
FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2020
3:30 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2020
4:58 PM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2020
3:34 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:50 PM
Cravatt Benjamin (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:45 PM
Brennan Aoife (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:29 PM
Cravatt Benjamin (Reporting)
FibroGen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2020
6:25 PM
Brennan Aoife (Reporting)
FibroGen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/06/2020
3:16 PM
FibroGen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2020
3:10 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
3:06 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2020
6:33 PM
FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
7:51 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
7:47 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/23/2020
3:59 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2020
5:35 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
5:59 AM
Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
8:22 PM
FibroGen (Issuer)
Rosenkranz Roberto Pedro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
6:48 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
6:47 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
6:46 PM
FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
6:45 PM
FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:34 PM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:33 PM
FibroGen (Issuer)
Rosenkranz Roberto Pedro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:32 PM
FibroGen (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:31 PM
FibroGen (Issuer)
Lema Gerald (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:30 PM
FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:28 PM
FibroGen (Issuer)
KEARNS THOMAS F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:27 PM
FibroGen (Issuer)
Ho Maykin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:26 PM
FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:25 PM
EDWARDS JEFFREY L (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:23 PM
Blaug Suzanne (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2020
3:05 PM
FibroGen (Filer)
Form DEF 14A
03/24/2020
4:24 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2020
4:37 PM
FibroGen (Issuer)
KEARNS THOMAS F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
6:55 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
7:05 PM
FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
7:03 PM
FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2020
7:00 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
3:06 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2020
4:27 PM
FibroGen (Subject)
Neff Thomas B (Filed by)
Form SC 13G/A
02/13/2020
4:36 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
8:52 PM
FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2020
3:40 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
8:01 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
8:16 PM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
8:14 PM
FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
8:12 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
8:10 PM
Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
8:09 PM
Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/06/2020
4:23 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2019
3:25 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
8:06 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2019
7:33 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
7:38 PM
FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
5:08 PM
FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
7:13 PM
FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
7:11 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
7:10 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2019
6:51 PM
FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
6:10 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2019
5:07 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
8:15 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
7:23 AM
FibroGen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
7:16 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2019
5:05 PM
FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
1:05 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2019
1:00 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2019
10:49 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2019
6:57 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2019
7:26 PM
FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2019
4:14 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2019
8:01 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2019
5:57 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 1/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.